Abstract
AN antibody against the mouse Ehrlich ascites carcinoma (EAC) can be conjugated with enough 131I to prevent the in vivo growth of EAC cells exposed in vitro to the radio-iodinated antibody1. To avoid the introduction of more than the minimum tumour-suppressive dose of the radio-iodinated antibody into EAC-bearing mice, it is necessary to determine the minimum EAC-suppressive dose of ionizing radiation acting alone or in conjunction with the anti-EAC antibody. The results presented here show that exposure of EAC cells to the anti-EAC antibody rendered them more susceptible to the tumour-suppressive effect of X-irradiation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ghose, T., Cerini, M., Carter, M., and Nairn, R. C., Brit. Med. J., 1, 90 (1967).
Kelly, L. S., Fed. Proc., 15, 108 (1956).
Cerini, M., thesis, Monash University, Melbourne, Australia (1968).
Klein, G., and Revesz, L., J. Nat. Cancer Inst., 14, 229 (1953).
Vermund, H., and Gollin, F. F., Cancer, 21, 58 (1968).
Klein, G., Clifford, P., Klein, E., and Stjernsward, J., in Treatment of Burkitt's Tumour (edit. by Burchenal, J. H., and Burkitt, D. P.) (Springer-Verlag, Berlin, 1967).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GHOSE, T., CERINI, M. Radiosensitization of Ehrlich Ascites Tumour Cells by a Specific Antibody. Nature 222, 993–994 (1969). https://doi.org/10.1038/222993a0
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1038/222993a0
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.